• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Kythera Biopharmaceuticals, Inc. (KYTH)

    -NMS
    48.18 Down 0.06(0.12%) Mar 27, 4:00PM EDT
    |After Hours : 48.18 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Net Income (24,223) (22,471) (19,482) (69,445)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation748  595  495  423  
    Adjustments To Net Income3,278  3,235  3,025  55,940  
    Changes In Accounts Receivables -   -   -   -  
    Changes In Liabilities3,760  3,439  636  (4,055)
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities605  926  921  2,121  
    Total Cash Flow From Operating Activities (15,832) (14,276) (14,405) (15,016)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(143)(1,122)(749)(42)
    Investments6,839  (27,045)6,917  (2,951)
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities 6,696   (28,167) 6,168   (2,993)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock139  49  131  1,080  
    Net Borrowings(1,513)(1,482)(1,451)(1,420)
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities (1,374) (1,433) (1,320) (340)
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (10,510) (43,876) (9,557) (18,349)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.